OCT4: Biological functions and clinical applications marker of germ cell neoplasia

Journal of Pathology

Volumn 211, Issue 1, 2007, Pages 1-9

  Cheng, L ^a   Sung, M T ^b   Cossu Rocca, P ^c   Jones, T D ^h   MacLennan, G T ^d   De Jong, J ^e   Lopez Beltran, A ^f   Montironi, R ^g   Looijenga, L H J ^e  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c UNIVERSITY OF SASSARI   (Italy)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF CÓRDOBA   (Spain)

^g UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^h NONE

Author keywords

Embryonal carcinoma; Germ cell tumuor; Oct3 4; POU5F1; Seminoma; Stem cell biomarkers; Testis

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TUMOR MARKER;

CANCER RISK; CARCINOGENESIS; CRYPTORCHISM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSGERMINOMA; EMBRYONAL CARCINOMA; EMBRYONIC STEM CELL; GENE EXPRESSION; GERM CELL TUMOR; GONADOBLASTOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFERTILITY; MALIGNANT TRANSFORMATION; NONHUMAN; OVARY TUMOR; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEMINOMA; TESTIS TUMOR; TUMOR BIOPSY;

BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; OCTAMER TRANSCRIPTION FACTOR-3; OVARIAN NEOPLASMS; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846228391     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2105     Document Type: Review

References (44)

1. Nichols J, Zernike B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998;95:379-391.
2. Donovan PJ. High Oct-ane fuel powers the stem cell. Nat Genet 2001;29:246-247.
3. Ovitt CE, Scholer HR. The molecular biology of Oct-4 in the early mouse embryo. Mol Hum Reprod 1998;4:1021-1031.
4. Pesce M, Scholer HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001;19:271-278.
5. Ben-Shushan E, Sharir H, Pikarsky E, Bergman Y. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor: retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells. Mol Cell Biol 1995;15:1034-1048.
6. Gidekel S, Bergman Y. A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element. J Biol Chem 2002;277:34521-34530.
7. Hattori N, Nishino K, Ko YG, Hattori N, Ohgane J, Tanaka S, et al. Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J Biol Chem 2004;279:17063-17069.
8. Deb-Rinker P, Ly D, Jezierski A, Sikorska M, Walker PR. Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. J Biol Chem 2005;280:6257-6260.
9. Gidekel S, Pizov G, Bergman Y, Pikarsky E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 2003;4:361-370.
10. Kehler J, Tolkunova E, Koschorz B, Pesce M, Gentile L, Boiani M, et al. Oct4 is required for primordial germ cell survival. EMBO Rep 2004;5:1078-1083.
11. Boiani M, Eckardt S, Scholer HR, McLaughlin KJ. Oct4 distribution and level in mouse clones: consequences for pluripotency. Genes Dev 2002;16:1209-1219.
12. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000;24:372-376.
13. Hay DC, Sutherland L, Clark J, Burdon T. Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 2004:22:225-235.
14. Velkey JM, O'Shea KS. Oct4 RNA interference induces trophectoderm differentiation in mouse embryonic stem cells. Genesis 2003;37:18-24.
15. van Berlo RJ, Oosterhuis JW, Schrijnemakers E, Schoots CJ. de Jong B, Darnjanov I. Yolk-sac carcinoma develops spontaneously as a late occurrence in slow-growing teratoid tumors produced from transplanted 7-day mouse embryos. Int J Cancer 1990;45:153-155.
16. Kraft HJ, Mosselman S, Smits HA, Hohenstein P, Pick E, Chen Q. et al. Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells. J Biol Chem 1996;271:12873-12878.
17. Palumbo C, van Roozendaal K, Gillis AJ, van Gurp RH, de Munnik H, Oosterhuis JW, et al. Expression of the PDGF alpha-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms. J Pathol 2002;196:467-477.
18. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA. Gillis AJ, van Roozendaal KE, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003;63:2244-2250.
19. Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 2004;28:935-940.
20. De Jong J, Stoop H, Dohle GR, Bangma CH, Kliffen M. van Esser JW, et al. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol 2005;206:242-249.
21. Reuter VE. Origins and molecular biology of testicular germ cell tumors. Mod Pathol 2005;18(Suppl 2):S51-S60.
22. Rajpert-De Meyts E, Hanstein R, Jorgensen N, Graem N, Vogt PH, Skakkebaek NE. Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod 2004;19:1338-1344.
23. Jones TD, Ulbright TM, Eble JN, Cheng L. OCT4: a sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res 2004;10:8544-8547.
24. Gaskell TL, Esnal A, Robinson LL, Anderson RA, Saunders PT. Immunohistochemical profiling of germ cells within the human fetal testis: identification of three subpopulations. Biol Reprod 2004;71:2012-2021.
25. Honecker F, Stoop H, de Krijger RR, Chris Lau YF, Bokemeyer C, Looijenga LH. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 2004;203:849-857.
26. Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. Arch Dis Child 2006;91:554-563.
27. Cools M, van Aerde K, Kersemaekers AM, Boter M, Drop SL. Wolffenbuttel KP, et al. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilisation syndromes. J Clin Endocrinol Metab 2005:90:5295-5303.
28. Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 2006;27:468-484.
29. Cools M, Stoop H, Kersemaekers AM, Drop SL, Wolffenbuttel KP, Bourguinon JP, et al. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. J Clin Endocrinol Metab 2006;91:2404-2413.
30. Jones TD, MacLennan GT, Bonnin JM, Varsegi MF, Blair JE, Cheng L. Screening for intratubular germ cell neoplasia of the testis using OCT4 immunohistochemistry. Am J Surg Pathol 2006;30:1427-1431.
31. Montironi R. Intratubular germ cell neoplasia of the testis: testicular intraepithelial neoplasia. Eur Urol 2002;41:651-654.
32. Cheng L, Thomas A, Roth LM, Zheng W, Michael H, Karim FW. OCT4: a novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol 2004;28:1341-1346.
33. Kersemaekers AM, Honecker F, Stoop H, Cools M, Molier M, Wolffenbuttel K, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/ 4 and TSPY. Hum Pathol 2005;36:512-521.
34. Stoop H, Honecker F, Cools M, de Krijger R, Bokemeyer C, Looijenga LH. Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study. Hum Reprod 2005;20:1466-1476.
35. Hattab EM, Tu PH, Wilson JD, Cheng L. OCT4 immunohistochemistry is superior to placental alkaline phosphatase (PLAP) in the diagnosis of central nervous system germinoma. Am J Surg Pathol 2005;29:368-371.
36. Sung MT, MacLennan GT, Cheng L. Retroperitoneal seminoma in limited biopsies: morphologic criteria and immunohistochemical findings in 30 cases. Am J Surg Pathol 2006;30:766-773.
37. Cheng L. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer 2004;101:2006-2010.
38. Barnea E, Bergman Y. Synergy of SF1 and RAR in activation of Oct-3/4 promoter. J Biol Chem 2000;275:6608-6619.
39. Berney DM, Shamash J, Pieroni K, Oliver RT. Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy? Histopathology 2001;39:382-385.
40. Sung MT, Jones TD, Beck SD, Foster RS, Cheng L. OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy. Hum Pathol 2006;37:662-667.
41. Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, Skakkebaek NE. Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Ann Oncol 2005;16:863-868.
42. De Gouveia Brazao CA, Pierik FH, Oosterhuis JW, Dohle GR, Looijenga LH, Weber RF. Bilateral testicular microlithiasis predicts the presence of the precursor of testicular germ cell tumors in subfertile men. J Urol 2004;171:158-160.
43. Dieckmann KP, Skakkebaek NE. Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer 1999;83:815-822.
44. Pauls K, Franke FE, Buttner R, Zhou H. Gonadoblastoma: evidence for a stepwise progression to dysgerminoma in a dysgenetic ovary. Virchows Arch 2005;447:603-609.